In this section of the General Tradeshow News Site, you'll find event-related news releases from PR Newswire. The releases are listed in chronological order and are archived by month and year.
-
-
Dec 7, 2020
Lumentum introduces new advanced telecom solutions and significant production capacity increase for datacom laser chips
-
Dec 6, 2020
IMBRUVICA® pooled clinical trial analyses presented at ASH demonstrate sustained efficacy and safety in patients with historically poor outcomes
-
Dec 6, 2020
Data demonstrate potential to differentiate between the two major forms of amyloidosis - ATTR and AL - and non invasive detection of systemic AL amyloidosis in multiple organ systems
-
-
Dec 5, 2020
Dr. Eunice Wang presents results of early-phase studies of investigational targeted treatments for AML; novel menin-KMT2A inhibitor appears to be safe and well-tolerated, and FLT3 inhibitor plus low-dose chemotherapy shows promising efficacy and safety
-
Dec 5, 2020
83% Overall Response Rate in Most Recent Evaluable Cohort of Heavily Pre-Treated Multiple Myeloma Patients
-
Dec 5, 2020
- BNZ-1 showed an overall response rate (ORR) of 63.2% based on the Global Response Score (GRS) in a heavily pretreated, relapsed and refractory CTCL patient population
-
-
-
-
-
Dec 4, 2020
This report will form the basis for policy recommendations headed into COP26
-
-
-
-
-
-
-
-
-
Dec 4, 2020
- C-CAR088 Anti-BCMA CAR-T Cell Therapy for Multiple Myeloma (MM)
-
-
Dec 4, 2020
- 15 scientific presentations highlight data on BRIVACT® (brivaracetam) CV, NAYZILAM® (midazolam) nasal spray CIV, VIMPAT® (lacosamide) CV, and others, illustrating UCB's commitment to developing new treatment options for patients in their treatment journey
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Dec 3, 2020
Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.com
-
-
Dec 3, 2020
- Two oral presentations on Iomab-B Phase 3 SIERRA trial
-
-
-
Dec 2, 2020
Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.com
-
-
-
-
-
-
Dec 2, 2020
The annual conference on enterprise content management, business process automation and digital transformation goes virtual, with keynotes from Marc Randolph, Dr. Nicol Turner-Lee, Ted Ross and Kate O'Neill.
-
Dec 2, 2020
TRICHOME™ Risk Protection Products Add Substantially to the NCRMA Innovative Risk Management Portfolio
-
Dec 2, 2020
First RH90 MPW shuttle launching for early customer IP development
-
-
Dec 2, 2020
Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.com
-
Dec 2, 2020
Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.com
-
Dec 2, 2020
Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.com
-
Dec 2, 2020
Rhinomed Ltd invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.com
-
Dec 2, 2020
Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.com
-
Dec 2, 2020
Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.com
-
-
Dec 2, 2020
22 scheduled presentations, including 10 oral presentations, examining blood cancers and other key hematology research
-
-
-
-
-
-
Dec 1, 2020
Week-long virtual event December 7-11 helps technical and executive attendees understand Secure Access Service Edge architecture
-
Dec 1, 2020
- Piper Sandler 32nd Annual Virtual Healthcare Conference on December 2 at 3:00pm ET
-
-
-
-
Dec 1, 2020
Genius Sports CEO & co-founder Mark Locke to discuss technology-driven global growth of sports betting industry at virtual fireside chat
-
-
-
-
-
-
-
Nov 30, 2020
Data From Innovative BiTE® Platform Include First Clinical Data for AMG 701 and Analyses From BLINCYTO® (blinatumomab) Phase 3 Pediatric Study
-
-
Nov 30, 2020
Presentation to showcase company's next generation solutions for treatment of chronic venous insufficiency
-
-
-
-
Nov 30, 2020
Rapid Adoption by Launching Oncolytics and Rare Disease Therapies Driving Team Expansion
-
Nov 30, 2020
Fireside chat with Clint Jones, co-founder and CEO, and Travis Matthiesen, CFO
-
-
-
-
-
-
-
-
-
-
Nov 27, 2020
- The 22nd CHTF China Smart City Expo Ends with Complete Success
-
-
-
-
Nov 26, 2020
Automechanika Shanghai 2020 is just around the corner, and SONTIAN is on the verge of making the exhibition event one of the most glamorous ever recorded
-
